| Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • Home
  • Marketing Services
  • Antibodies
  • Careers
  • Directories
  • Drugs
  • Events
  • Genes
  • InDepth
  • News
  • Reports
  • Videos
  • A-Z
  • Members Login
  • Post an Event
  • Search Events
  • September 09
  • October 09
  • November 09
  • December 09
 Calendar
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
   Day      Week     Month  
1 1 1 1 1
 
1 1 1 1 1 1 1 1 1 1 1 1
   Search      Add Event  
1 1 1


Search Results

Nov 2009
  S M T W T F S
W44 1 2 3 4 5 6 7
W45 8 9 10 11 12 13 14
W46 15 16 17 18 19 20 21
W47 22 23 24 25 26 27 28
W48 29 30 1 2 3 4 5


Today is:
Thu, Nov 26, 2009


Subscribe & download

Filter events



Mon, Jun 7, 2010
 Cardiovascular Clinical Trials in Emerging Markets 2010 - Conference (Prague, Czech Republic)
The globalisation of clinical trials has meant that increasingly pharmaceutical and biotechnology companies are turning towards performing clinical trials in emerging markets such as Asia Pacific, Central and Eastern Europe, Latin America and the Middle east. Within these emerging markets, the ability to research new products can also provide a way to maximize its potential use in countries typically not considered for commercial viability. However cultural, ethical, logistical and regulatory challenges can prove to be the biggest roadblocks when conducting trials in emerging countries and this is particularly true when conducting cardiovascular clinical trials. The Congress will focus on the current results, problems and solutions of conducting cardiovascular clinical trials in key emerging markets as well as examining the challenges facing the pharmaceutical industry in pursuing a contemporary approach in the development of drugs and treatment in key areas.
Tue, Jun 8, 2010
 Cardiovascular Clinical Trials in Emerging Markets 2010 - Conference (Prague, Czech Republic)
The globalisation of clinical trials has meant that increasingly pharmaceutical and biotechnology companies are turning towards performing clinical trials in emerging markets such as Asia Pacific, Central and Eastern Europe, Latin America and the Middle east. Within these emerging markets, the ability to research new products can also provide a way to maximize its potential use in countries typically not considered for commercial viability. However cultural, ethical, logistical and regulatory challenges can prove to be the biggest roadblocks when conducting trials in emerging countries and this is particularly true when conducting cardiovascular clinical trials. The Congress will focus on the current results, problems and solutions of conducting cardiovascular clinical trials in key emerging markets as well as examining the challenges facing the pharmaceutical industry in pursuing a contemporary approach in the development of drugs and treatment in key areas.



powered by VTCalendar 2.2.1

  • Email List Rental
  • Address List Rental
  • Connect by email
  • News feeds RSS
  • Reports
  • User Agreements
  • Need Help?
  • Post Events
  • Post Jobs
  • Post Company Profile
  • Post a Video
  • Post Product Information
  • Post a Press Release
  • Advertising
  • Search
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.